biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	98D9BCFF-F6F9-4718-98D4-6A65B78DBA7E
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-WJ-A86L-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-WJ-A86L-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-WJ-A86L-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788057
biospecimen__bio__day_of_creation	05
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-WJ-A86L.2C93F65E-88FD-405F-86F1-0E35C7F46DC2.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	F
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-WJ-A86L
biospecimen__shared__patient_id	A86L
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	0D826B46-BE6C-42F0-BD46-EBC87279C432
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.4
clinical__chol_lihc_shared__albumin_result_specified_value	4.2
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	16
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	2.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	3.0
clinical__chol_lihc_shared__platelet_result_lower_limit	125000
clinical__chol_lihc_shared__platelet_result_upper_limit	415000
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__bcr_followup_barcode	TCGA-WJ-A86L-F65568
clinical__clin_shared__bcr_followup_uuid	12FDF77B-672C-44DD-A092-DEAD092E0C7E
clinical__clin_shared__day_of_form_completion	29
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	257000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	8529642e-ca3e-4c47-a3eb-e3c25f9c4a6f
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-WJ-A86L-01A-12R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	29ef5404-ecb1-48f6-91b8-ad301939a3fb
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	fff02eb8-2da6-4d6f-8bce-8cffdd73980d
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	63d475ef-8f26-45ed-ae80-cfa87e68b2f5
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:29:32.212662-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	322cc545-dec3-5db9-93fc-4203393e4e12
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1945
gdc__diagnoses__age_at_diagnosis	25018
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25018.0
gdc__diagnoses__days_to_last_follow_up	345.0
gdc__diagnoses__diagnosis_id	381164d4-736c-5efa-ba76-a670750e7022
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8310/3
gdc__diagnoses__primary_diagnosis	Clear cell adenocarcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.151022507021082
gdc__exposures__exposure_id	fd099577-ee95-5500-b294-1a6684641cfb
gdc__exposures__height	159.0
gdc__exposures__weight	56.0
gdc__file_id	b9d2753e-8189-441d-9528-60de47b4a32c
gdc__file_name	5150ee00-a2b3-4cc5-a619-9676604c66c1.mirbase21.mirnas.quantification.txt
gdc__file_size	50261
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	d471da284faa284c893c89c078e0fd04
gdc__portions__is_ffpe	false
gdc__portions__portion_id	bd0455b6-44dc-4cbd-a156-5112e7e92bdb
gdc__portions__portion_number	12
gdc__portions__weight	10.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	95
gdc__samples__initial_weight	270.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	2C93F65E-88FD-405F-86F1-0E35C7F46DC2
gdc__samples__sample_id	ab5ccf89-2c0d-4b45-be11-5c859c1cf427
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	bb2110e6-35c9-4d54-b0e1-22baf6696ffa
gdc__submitter_id	mirna_swap_dr11_13_MirnaExpressionbbdd98d6-bda5-4904-b989-489746fa3b34_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	WJ
gdc__tissue_source_site__name	Greenville Health System
gdc__tissue_source_site__tissue_source_site_id	73d67bfc-0459-5e54-8bf1-ebcd1c12a4c7
gdc__treatments__treatment_id	67798971-aa46-5dec-a5d5-466e267119ee
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:49.324+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8529642e-ca3e-4c47-a3eb-e3c25f9c4a6f-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8529642e-ca3e-4c47-a3eb-e3c25f9c4a6f-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129632
manually_curated__local_md5	2fbd179f0aaafac5e6720ccd6759e7cd
manually_curated__opengdc_download_date	2018-10-16T17:12:32.000038+02:00
manually_curated__opengdc_file_md5	836adbb63d531bd503dd5039aa3ea38e
manually_curated__opengdc_file_size	50260
manually_curated__opengdc_id	8529642e-ca3e-4c47-a3eb-e3c25f9c4a6f-meq
manually_curated__origin_file_size	129632
manually_curated__origin_last_modified_date	Tue Oct 16 17:42:00 CEST 2018
manually_curated__origin_md5	2fbd179f0aaafac5e6720ccd6759e7cd
manually_curated__tissue_status	tumoral
